ASM more aligned with us. First get the arbitration result in our favour then we can talk to Somboon.
Fair valuation should be 30c to 40c under normal circumstances and based on current likely EBITDA of between 35 to 40 mil with zero improvement.
- Forums
- ASX - By Stock
- DNA
- Ann: Director Resignation
Ann: Director Resignation, page-131
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DNA (ASX) to my watchlist
|
|||||
Last
3.5¢ |
Change
0.002(6.06%) |
Mkt cap ! $43.23M |
Open | High | Low | Value | Volume |
3.4¢ | 3.5¢ | 3.4¢ | $4.673K | 134.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 211401 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 3974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 211401 | 0.034 |
4 | 128266 | 0.033 |
4 | 223134 | 0.032 |
2 | 57290 | 0.031 |
4 | 913353 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 3974 | 1 |
0.037 | 70000 | 1 |
0.039 | 477212 | 4 |
0.040 | 386936 | 1 |
0.041 | 78720 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
DNA (ASX) Chart |